{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:29:10Z","timestamp":1786717750505,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0253-7613.174545","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:42Z","timestamp":1467158442000},"page":"59","source":"Crossref","is-referenced-by-count":8,"title":["Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart"],"prefix":"10.4103","volume":"48","author":[{"given":"HarlokeshNarayan","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PL","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.174545-1","first-page":"3172","volume-title":"Hyperlipidemia and coronary disease.Correction of the increased thrombogenic potential with cholesterol reduction","author":"Lacoste","year":"1995","journal-title":"Am Heart Assoc"},{"key":"key-10.4103\/0253-7613.174545-2","first-page":"1124","volume-title":"Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium","author":"Murry","year":"1986","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.174545-3","first-page":"559","volume-title":"Ischemic preconditioning in humans: Models, mediators, and clinical relevance","author":"Tomai","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.174545-4","first-page":"1108","volume-title":"Possible mechanisms involved in attenuated cardioprotection in high fat diet induced hyperlipidemic rat hearts","author":"Gagandeep","year":"2011","journal-title":"J Pharm Res"},{"key":"key-10.4103\/0253-7613.174545-5","first-page":"e62012","volume-title":"Novel insulin sensitizer modulates nutrient sensing pathways and maintains \u00df-cell phenotype in human islets","author":"Rohatgi","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0253-7613.174545-6","first-page":"H1558","volume-title":"Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction","author":"Yasuda","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key-10.4103\/0253-7613.174545-7","first-page":"817","volume-title":"Pioglitazone mimics preconditioning in the isolated perfused rat heart: A role for the prosurvival kinases PI3K and P42\/44MAPK","author":"Wynne","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"key-10.4103\/0253-7613.174545-8","first-page":"2903","volume-title":"PKB\/Akt: A key mediator of cell proliferation, survival and insulin responses?","author":"Lawlor","year":"2001","journal-title":"J Cell Sci"},{"key":"key-10.4103\/0253-7613.174545-9","first-page":"567","volume-title":"Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B","author":"Stokoe","year":"1997","journal-title":"Science"},{"key":"key-10.4103\/0253-7613.174545-10","first-page":"679","volume-title":"Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase\/Akt\/mammalian target of rapamycin pathway","author":"Granville","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0253-7613.174545-11","first-page":"355","volume-title":"Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia","author":"Luo","year":"2006","journal-title":"Cell Metab"},{"key":"key-10.4103\/0253-7613.174545-12","first-page":"1588","volume-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors","author":"O\u2032Donnell","year":"2008","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0253-7613.174545-13","first-page":"75","volume-title":"Involvement of GSK-3\u00df in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart","author":"Yadav","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0253-7613.174545-14","doi-asserted-by":"crossref","unstructured":"Lorkowska B, Bartus M, Franczyk M, Kostogrys RB, Jawein J, Pisulewski PM, et al. Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats. J Pharmacol Exp Ther 2006;1019-26.","DOI":"10.1124\/jpet.105.098798"},{"key":"key-10.4103\/0253-7613.174545-15","first-page":"59","volume-title":"Reactive oxygen species function as second messenger during ischemic preconditioning of heart","author":"Das","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0253-7613.174545-16","first-page":"113","volume-title":"Isolated heart perfusion according to Langendorff-still viable in the new millennium","author":"Skrzypiec-Spring","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"key-10.4103\/0253-7613.174545-17","first-page":"593","volume-title":"Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique","author":"Fishbein","year":"1981","journal-title":"Am Heart J"},{"key":"key-10.4103\/0253-7613.174545-18","first-page":"71","volume-title":"Decrease of myocardial infarct size with desferrioxamine: Possible role of oxygen free radicals in its ameliorative effect","author":"Chopra","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0253-7613.174545-19","first-page":"149","volume-title":"Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart","author":"Parikh","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"key-10.4103\/0253-7613.174545-20","first-page":"129","volume-title":"Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection","author":"Parikh","year":"1999","journal-title":"Pharmacol Res"},{"key":"key-10.4103\/0253-7613.174545-21","first-page":"283","volume-title":"Myocardial ischaemia\/reperfusion injury and preconditioning: Effects of hypercholesterolaemia\/hyperlipidaemia","author":"Ferdinandy","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0253-7613.174545-22","first-page":"2149","volume-title":"Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits","author":"Tang","year":"2005","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.174545-23","first-page":"154","volume-title":"Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: Role of matrix metalloproteinase-2 inhibition","author":"Giricz","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0253-7613.174545-24","first-page":"78","volume-title":"Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart","author":"Yadav","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0253-7613.174545-25","first-page":"659","volume-title":"Insulin and ischemic preconditioning induce cardioprotective GSK 3\u03b2 blockade via STAT3 signaling in the isolated rat heart","author":"Fuglesteg","year":"2006","journal-title":"Acta Physiol"},{"key":"key-10.4103\/0253-7613.174545-26","first-page":"20","volume-title":"Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms","author":"Fullmer","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"key-10.4103\/0253-7613.174545-27","first-page":"623","volume-title":"The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus rats","author":"Sasaki","year":"2007","journal-title":"Int Heart J"},{"key":"key-10.4103\/0253-7613.174545-28","first-page":"273","volume-title":"Pretreatment with insulin before ischaemia reduces infarct size in Langendorff-perfused rat hearts","author":"Fuglesteg","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"key-10.4103\/0253-7613.174545-29","first-page":"49","volume-title":"GSK-3\u00df at the crossroads in the signalling of heart preconditioning: Implication of mTOR and Wnt pathways","author":"Vigneron","year":"2011","journal-title":"Cardiovasc Res"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:27:55Z","timestamp":1786714075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.174545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["174545"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.174545","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}